SLNO – Soleno Therapeutics Inc
SLNO — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
18.82
Margin Of Safety %
-42
Put/Call OI Ratio
1.2
EPS Next Q Diff
0.14
EPS Last/This Y
3.49
EPS This/Next Y
2.67
Price
52.36
Target Price
70.89
Analyst Recom
2.64
Performance Q
15.77
Upside
-85.3%
Beta
-2.78
Ticker: SLNO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | SLNO | 39.82 | 0.35 | 0.05 | 36226 |
| 2026-03-10 | SLNO | 40.62 | 0.35 | 0.01 | 36347 |
| 2026-03-11 | SLNO | 39.07 | 0.35 | 12.58 | 36437 |
| 2026-03-12 | SLNO | 36.78 | 0.35 | 1.21 | 36590 |
| 2026-03-13 | SLNO | 36.74 | 0.35 | 1.09 | 36590 |
| 2026-03-17 | SLNO | 33.63 | 0.69 | 8.60 | 47527 |
| 2026-03-18 | SLNO | 32.8 | 0.69 | 9.28 | 47495 |
| 2026-03-20 | SLNO | 33.21 | 0.78 | 0.22 | 53091 |
| 2026-03-25 | SLNO | 31.84 | 1.04 | 0.12 | 36820 |
| 2026-03-26 | SLNO | 31.67 | 1.02 | 3.43 | 37161 |
| 2026-03-27 | SLNO | 30.06 | 1.25 | 7.25 | 41379 |
| 2026-03-30 | SLNO | 30.47 | 1.41 | 0.06 | 45462 |
| 2026-03-31 | SLNO | 33.35 | 1.39 | 0.10 | 45797 |
| 2026-04-01 | SLNO | 36.96 | 1.28 | 0.15 | 47831 |
| 2026-04-06 | SLNO | 52.26 | 1.15 | 0.87 | 51162 |
| 2026-04-07 | SLNO | 52.3 | 1.20 | 0.74 | 89693 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | SLNO | 39.81 | - | - | 3.99 |
| 2026-03-10 | SLNO | 40.62 | - | - | 3.99 |
| 2026-03-11 | SLNO | 39.07 | - | - | 3.99 |
| 2026-03-12 | SLNO | 36.75 | - | - | 4.04 |
| 2026-03-13 | SLNO | 33.75 | - | - | 4.04 |
| 2026-03-17 | SLNO | 33.64 | - | - | 4.04 |
| 2026-03-18 | SLNO | 32.80 | - | - | 4.04 |
| 2026-03-19 | SLNO | 33.63 | - | - | 4.04 |
| 2026-03-20 | SLNO | 33.22 | - | - | 3.89 |
| 2026-03-23 | SLNO | 31.74 | - | - | 3.89 |
| 2026-03-24 | SLNO | 31.31 | - | - | 3.89 |
| 2026-03-25 | SLNO | 31.85 | - | - | 3.89 |
| 2026-03-26 | SLNO | 31.84 | - | - | 3.89 |
| 2026-03-27 | SLNO | 30.06 | - | - | 3.89 |
| 2026-03-30 | SLNO | 30.46 | - | - | 3.89 |
| 2026-03-31 | SLNO | 33.47 | - | - | 3.89 |
| 2026-04-01 | SLNO | 36.97 | - | - | 3.89 |
| 2026-04-02 | SLNO | 39.49 | - | - | 3.89 |
| 2026-04-06 | SLNO | 52.26 | - | - | 3.89 |
| 2026-04-07 | SLNO | 52.36 | - | - | 3.89 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | SLNO | 0.00 | -1.27 | 19.57 |
| 2026-03-10 | SLNO | 0.00 | -1.27 | 19.57 |
| 2026-03-11 | SLNO | 0.00 | -1.27 | 17.89 |
| 2026-03-12 | SLNO | 0.00 | -1.27 | 17.89 |
| 2026-03-13 | SLNO | 0.00 | -1.27 | 17.89 |
| 2026-03-18 | SLNO | 0.00 | -1.51 | 17.89 |
| 2026-03-19 | SLNO | 0.00 | -1.51 | 17.89 |
| 2026-03-20 | SLNO | 0.00 | -1.51 | 17.89 |
| 2026-03-23 | SLNO | 0.00 | -1.40 | 17.89 |
| 2026-03-24 | SLNO | 0.00 | -1.40 | 17.89 |
| 2026-03-25 | SLNO | 0.00 | -1.40 | 18.82 |
| 2026-03-26 | SLNO | 0.00 | -1.40 | 18.82 |
| 2026-03-27 | SLNO | 0.00 | -1.40 | 18.82 |
| 2026-03-30 | SLNO | 0.00 | -1.29 | 18.82 |
| 2026-03-31 | SLNO | 0.00 | -1.29 | 18.82 |
| 2026-04-01 | SLNO | -0.69 | -1.29 | 18.82 |
| 2026-04-02 | SLNO | -0.69 | -1.29 | 18.82 |
| 2026-04-06 | SLNO | -0.69 | -0.39 | 18.82 |
| 2026-04-07 | SLNO | -0.69 | -0.39 | 18.82 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.8
Avg. EPS Est. Current Quarter
0.66
Avg. EPS Est. Next Quarter
0.94
Insider Transactions
-0.69
Institutional Transactions
-0.39
Beta
-2.78
Average Sales Estimate Current Quarter
93
Average Sales Estimate Next Quarter
113
Fair Value
30.54
Quality Score
82
Growth Score
23
Sentiment Score
81
Actual DrawDown %
42
Max Drawdown 5-Year %
-95.5
Target Price
70.89
P/E
234.86
Forward P/E
8.33
PEG
0.05
P/S
14.19
P/B
6.08
P/Free Cash Flow
57.92
EPS
0.22
Average EPS Est. Cur. Y
3.89
EPS Next Y. (Est.)
6.56
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
10.75
Relative Volume
6.74
Return on Equity vs Sector %
-22.9
Return on Equity vs Industry %
-6.4
EPS 1 7Days Diff
-0.2
EPS 1 30Days Diff
-0.32
EBIT Estimation
◆
SLNO
Healthcare
$52.35
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
77.9
Range 1M
99.5%
Sup Dist
0.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
912.4%
EPS NY
59.2%
52W%
37.5%
Long-Term Value
Quality companies, undervalued
WATCH
🟢 BUY
+163.9% upside
Upside
+163.9%
Quality
82
MoS
-42%
Soleno Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 182
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
SLNO
Latest News
—
Caricamento notizie per SLNO…
stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today
news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance
stock history SLNO – Soleno Therapeutics Inc invest stock market
stock prices SLNO premarket after hours
ticker SLNO fair value insiders trading